Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study

Clinical trial NCT04400474 · COMPLETED

Trial details

NCT number: NCT04400474
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumor Anaplastic Thyroid Cancer Adenocarcinoma Pheochromocytoma Paraganglioma

Start date: 2020-10-07
Primary completion: 2023-11-23
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.